A new study conducted at the Harvard T.H. Chain School of Public Health in Boston indicates that snus, a smokeless tobacco product, may increase risk of death in a patient with prostate cancer. According to study co-author Kathryn Wilson, the study, conducted on thousands of Swedish men from 1971-1992, determined that "those who used snus but did not smoke has a 24% higher risk of death from prostate cancer during the study period."
To read more about this study, click here.
No comments:
Post a Comment